Patients with RASopathy-associated HCM were excluded from our study and we still find an upregulation of FGF-21 with an OR for HCM of 10.0 (p = 0.001) compared with their controls, using the dichotomized variables. This evidence concerns the gene FGF21 and RASopathy.